Highlights from ASCO20 Virtual: Melanoma
This episode features Dr. Michael Smylie, Dr. Marcus Butler, and Dr. Jason Luke. This program was made possible by unrestricted sponsorship support from Merck. Trials Discussed: Advanced Melanoma: LN-144: 00:01:03 Adjuvant Melanoma: COMBI-AD a EORTC 1325-MG/KEYNOTE 054: 00:10:41 Metastatic Melanoma: COMBO IMMUNOTHERAPY (NIVOLIMAB + IPILUMAB): 00:28:55 Advanced Melanoma: KEYNOTE-006: 00:38:13 Neoadjuvant Melanoma: PRADO (Follow up of OpACIN-neo): 00:47:47 Advanced Melanoma: LOW-DOSE IPI + PEMBRO IN MEL 53: 00:54:40
